---
pmid: '26949185'
title: BOK Is a Non-canonical BCL-2 Family Effector of Apoptosis Regulated by ER-Associated
  Degradation.
authors:
- Llambi F
- Wang YM
- Victor B
- Yang M
- Schneider DM
- Gingras S
- Parsons MJ
- Zheng JH
- Brown SA
- Pelletier S
- Moldoveanu T
- Chen T
- Green DR
journal: Cell
year: '2016'
full_text_available: false
pmcid: PMC5018360
doi: 10.1016/j.cell.2016.02.026
---

# BOK Is a Non-canonical BCL-2 Family Effector of Apoptosis Regulated by ER-Associated Degradation.
**Authors:** Llambi F, Wang YM, Victor B, Yang M, Schneider DM, Gingras S, Parsons MJ, Zheng JH, Brown SA, Pelletier S, Moldoveanu T, Chen T, Green DR
**Journal:** Cell (2016)
**DOI:** [10.1016/j.cell.2016.02.026](https://doi.org/10.1016/j.cell.2016.02.026)
**PMC:** [PMC5018360](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5018360/)

## Abstract

1. Cell. 2016 Apr 7;165(2):421-33. doi: 10.1016/j.cell.2016.02.026. Epub 2016 Mar
 3.

BOK Is a Non-canonical BCL-2 Family Effector of Apoptosis Regulated by 
ER-Associated Degradation.

Llambi F(1), Wang YM(2), Victor B(3), Yang M(3), Schneider DM(3), Gingras S(3), 
Parsons MJ(3), Zheng JH(4), Brown SA(3), Pelletier S(3), Moldoveanu T(4), Chen 
T(2), Green DR(5).

Author information:
(1)Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 
38105, USA. Electronic address: fabien.llambi@stjude.org.
(2)Department of Chemical Biology and Therapeutics, St. Jude Children's Research 
Hospital, Memphis, TN 38105, USA.
(3)Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 
38105, USA.
(4)Department of Chemical Biology and Therapeutics, St. Jude Children's Research 
Hospital, Memphis, TN 38105, USA; Department of Structural Biology, St. Jude 
Children's Research Hospital, Memphis, TN 38105, USA.
(5)Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 
38105, USA. Electronic address: douglas.green@stjude.org.

Comment in
    Curr Biol. 2016 Jun 6;26(11):R473-6. doi: 10.1016/j.cub.2016.04.003.

The mitochondrial pathway of apoptosis is initiated by mitochondrial outer 
membrane permeabilization (MOMP). The BCL-2 family effectors BAX and BAK are 
thought to be absolutely required for this process. Here, we report that BCL-2 
ovarian killer (BOK) is a bona fide yet unconventional effector of MOMP that can 
trigger apoptosis in the absence of both BAX and BAK. However, unlike the 
canonical effectors, BOK appears to be constitutively active and unresponsive to 
antagonistic effects of the antiapoptotic BCL-2 proteins. Rather, BOK is 
controlled at the level of protein stability by components of the endoplasmic 
reticulum (ER)-associated degradation pathway. BOK is ubiquitylated by the 
AMFR/gp78 E3 ubiquitin ligase complex and targeted for proteasomal degradation 
in a VCP/p97-dependent manner, which allows survival of the cell. When 
proteasome function, VCP, or gp78 activity is compromised, BOK is stabilized to 
induce MOMP and apoptosis independently of other BCL-2 proteins.

Copyright Â© 2016 Elsevier Inc. All rights reserved.

DOI: 10.1016/j.cell.2016.02.026
PMCID: PMC5018360
PMID: 26949185 [Indexed for MEDLINE]

Conflict of interest statement: The authors declare no conflict of interest.
